Evidence map›Paper›PMID 40223093›Full record

ArticleCell death discovery2025

An in vivo "turning model" reveals new RanBP9 interactions in lung macrophages.

Yasuko Kajimura, Shuxin Dong, Anna Tessari, Arturo Orlacchio, Alexandra Thoms, Maria Concetta Cufaro, Federica Di Marco, Foued Amari, Min Chen, Shimaa H A Soliman and 13 more

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation.Journal of experimental & clinical cancer research : CR · 2025
    Article
4 · The record

Corrections and comments

  • Update of
    An2024
5 · Who and what money

Authors and funding

23 authors.

Yasuko KajimuraDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Shuxin DongDepartment of Nutritional Sciences, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, TX, 78723, USA.
Anna TessariDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Arturo OrlacchioDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Alexandra ThomsDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Maria Concetta CufaroAnalytical Biochemistry and Proteomics Research Unit, CAST (Center for Advanced Studies and Technology), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.ORCID http://orcid.org/0000-0002-6457-7795
Federica Di MarcoAnalytical Biochemistry and Proteomics Research Unit, CAST (Center for Advanced Studies and Technology), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Foued AmariGenetically Engineered Mouse Modeling Core, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Min ChenGenetically Engineered Mouse Modeling Core, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Shimaa H A SolimanDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Lara RizzottoGene Editing Shared Resource, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Liwen ZhangProteomic Shared Resource, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Damu SunilkumarDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Joseph M AmannDivision of Medical Oncology, Ohio State Wexner Medical Center, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
David P CarboneDivision of Medical Oncology, Ohio State Wexner Medical Center, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.ORCID http://orcid.org/0000-0003-3002-1921
Amer AhmedDepartment of Biosciences, Biotechnology and Environment, University of Bari, 70125, Bari, Italy.
Giuseppe FiermonteDepartment of Biosciences, Biotechnology and Environment, University of Bari, 70125, Bari, Italy.ORCID http://orcid.org/0000-0002-6764-9395
Mike A FreitasDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.
Alessia LodiDepartment of Nutritional Sciences, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, TX, 78723, USA.
Piero Del BoccioAnalytical Biochemistry and Proteomics Research Unit, CAST (Center for Advanced Studies and Technology), University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.ORCID http://orcid.org/0000-0003-1653-2194
Lino TessarolloNeural Development Section, Mouse Cancer Genetics Program, NCI/Center for Cancer Research, NIH, Frederick, MD, 21702, USA.
Dario PalmieriDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA.ORCID http://orcid.org/0000-0002-0797-4268
Vincenzo CoppolaDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University Arthur G. James Comprehensive Cancer Center, Columbus, OH, 43210, USA. vincenzo.coppola@osumc.edu.ORCID http://orcid.org/0000-0001-6163-1779

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
TURNing RanBP9 on NSCLCR03CA259389 · NCI · OHIO STATE UNIVERSITY · PI COPPOLA, VINCENZO · 2021 to 2022
$154k
NCI NIH HHS P30 CA016058NCI NIH HHS R03 CA259389Ohio State University (OSU) GR123713U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R03CA259389
6 · The paper itself

Abstract

The biological functions of the scaffold protein Ran Binding Protein 9 (RanBP9) remain elusive in macrophages or any other cell type where this protein is expressed together with its CTLH (C-terminal to LisH) complex partners. We have engineered a new mouse model, named RanBP9-TurnX, where RanBP9 fused to three copies of the HA tag (RanBP9-3xHA) can be turned into RanBP9-V5 tagged upon Cre-mediated recombination. We created this model to enable stringent biochemical studies at cell type specific level throughout the entire organism. Here, we have used this tool crossed with LysM-Cre transgenic mice to identify RanBP9 interactions in lung macrophages. We show that RanBP9-V5 and RanBP9-3xHA can be both co-immunoprecipitated with the known members of the CTLH complex from the same whole lung lysates. However, more than ninety percent of the proteins pulled down by RanBP9-V5 differ from those pulled-down by RanBP9-HA. The lung RanBP9-V5 associated proteome includes previously unknown interactions with macrophage-specific proteins as well as with players of the innate immune response, DNA damage response, metabolism, and mitochondrial function. This work provides the first lung specific RanBP9-associated interactome in physiological conditions and reveals that RanBP9 and the CTLH complex could be key regulators of macrophage bioenergetics and immune functions.

Identifiers

PMID40223093
PMCPMC11994786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.